Theriva Biologics, INC S-1 registration statements

Theriva Biologics is offering up to 8,403,361 shares of common stock along with warrants in a best efforts offering to raise capital for working capital and general corporate purposes.

Theriva Biologics is planning a best-efforts public offering of up to 6,756,756 shares of common stock and accompanying warrants, or pre-funded warrants, to raise capital for working capital and general corporate purposes.

Theriva Biologics is planning a public offering of up to 7,692,307 shares of common stock, along with warrants, to raise capital for working capital and general corporate purposes.

Theriva Biologics is offering up to 2,173,913 shares of common stock, along with common warrants and pre-funded warrants, in a best efforts offering to raise capital for working capital and general corporate purposes.

Theriva Biologics plans to offer shares of common stock and warrants in a public offering to raise capital for working capital and general corporate purposes.